The clearest answer begins with the medicine in front of you. Historical Geref products containing sermorelin had FDA approvals. A present-day compounded sermorelin prescription does not inherit those approvals simply because it contains the same named active ingredient.
That distinction can get lost in a short advertisement. A discontinued drug, an approved use, a licensed pharmacy, and a compounded preparation describe different things. Knowing which claim a seller is making helps you ask for evidence that actually applies to your prescription.
Historical approval is not approval of a current compounded product or every advertised use.
What the historical record says
A March 2013 FDA notice describes two Geref applications, originally approved in 1990 and 1997. The notice discusses diagnostic use and treatment of growth hormone deficiency in children. It records FDA's determination that the specified products were not withdrawn from sale for reasons of safety or effectiveness.
That is a particular regulatory finding about discontinued products. It is not a declaration that any sermorelin product sold today has been reviewed, or that adult anti-aging claims were approved. The notice should be read for what it decided, without adding a broader assurance that is not there.
Why a compounded preparation has a different status
FDA explains that compounded drugs do not undergo its premarket review for safety, effectiveness, and quality. Compounding can meet an individual patient's medical needs, but the preparation is not an FDA-approved generic simply because it resembles an older medicine.
Ask the prescriber why the proposed formula is appropriate and ask the pharmacy for the complete label. Strength, ingredients, route, and storage instructions belong to that specific preparation. Our oral-versus-injection comparison shows why changing the route adds another evidence question.
Separate the pharmacy from the medicine
A business license tells you something about the business and its authorization. It does not mean FDA has approved every product that business prepares. Similarly, a website verification mark should not be read as a guarantee of a particular patient's outcome.
Use the pharmacy verification guide to identify the actual dispensing pharmacy and the relevant licensing authority. Keep a copy of the dispensing label. If promotional wording is unclear, ask whether the claim concerns the facility, an ingredient, a historical product, or the exact preparation being offered.
The intended use needs its own evidence
Even a familiar ingredient can be discussed for a purpose quite different from its historical use. Better sleep, easier weight loss, and slower aging are not interchangeable outcomes. An explanation of hormone signaling does not establish that a preparation reliably produces all three.
The Endocrine Society distinguishes normal aging from endocrine disease. Read sermorelin and sleep or weight-loss claims for a closer look at those separate questions. A clinician should explain the condition under consideration and the uncertainty around the proposed treatment.
A prescription and an approval answer different questions
A prescription reflects a clinician's treatment decision. FDA approval is a product-specific regulatory determination. Seeing a prescription requirement on a website does not by itself establish the approval status, suitability, or clinical evidence of what will be dispensed.
Before proceeding, ask for four details in writing: the exact preparation, its approval or compounding status, the intended purpose, and the evidence supporting that purpose. Then ask what alternatives were considered. Our first-appointment guide can help turn those details into a conversation you can follow without becoming an expert in regulatory terminology.
Follow the sources.
Provider pages establish advertised terms, not independently measured outcomes. General medical guidance does not validate every compounded preparation.
- FDA Federal Register: Geref withdrawal determination (2013) (opens in a new tab)
Historical determination that specified Geref products were not withdrawn for safety or effectiveness. Not approval of current compounded preparations or adult anti-aging use.
- FDA: Compounding questions and answers (opens in a new tab)
Compounded medicines differ from FDA-approved generic drugs.
- FDA: Risks of compounded drugs (opens in a new tab)
Explains lack of FDA approval and the risks of poor-quality compounded preparations.
- FDA: Managing the benefits and risks of medicines (opens in a new tab)
General questions for evaluating benefit, follow-up and new medicines.
- Endocrine Society: Hormones and aging statement overview (opens in a new tab)
Checked September 23, 2026. Distinguishes normal aging from disease and identifies the lack of an approved GH anti-aging intervention.
